May 31, 2022
Article
“We found that black patients had lower odds of using telemedicine services,” said lead study author Jenny S. Guadamuz, PhD.
February 20, 2022
Article
Lead study author Chung-Han Lee, MD, PhD, said that while the findings were “disappointing from a biomarker development standpoint,” the results confirm the effectiveness of the regimen across various lines of treatment.
September 19, 2021
Article
There was limited clinical activity with the combination in patients with HRD-negative tumors.
February 15, 2021
Article
The combination of the anti–PD-1 immunotherapy and the multikinase inhibitor also extended progression-free survival in the phase 3 KEYNOTE-581/CLEAR trial (Study 307).